Saturday 17 October 2026 Export RXRX’s income statement to Excel — free account

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $74.7 million, up 26.9% from fiscal 2024. In the quarter to June 2026, revenue fell 60.1%, EPS grew 39.0%, free cash flow fell 32.0% and total debt fell 66.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

3.47 0.69 −16.59%

Follow RXRX

Alert me

Market cap: $2.2B
P/E: 0.0×
Fwd P/E: −3.8×
Dividend yield: —
F-score: 3/9
Altman Z: 0.37
Beneish M: −1.72
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	5	5
ROE Full definition →		(91.06%)	(59.54%)	(57.16%)	(56.58%)
ROA Full definition →		(67.31%)	(44.12%)	(42.33%)	(41.26%)
ROIC Full definition →		(114.23%)	(103.19%)	(98.34%)	(92.22%)
Return on Tangible Assets Full definition →		(106.68%)	(83.84%)	(82.85%)	(90.52%)
Average Days of Receivables Full definition →		183.05	120.47	74.67	95.77
Free Cash Flow per Share Full definition →		(1.01)	(0.85)	(0.62)	(0.67)
Free Cash Flow Full definition →		(450.20)	(380.43)	(328.08)	(354.26)
Capital Expenditures Full definition →		(9.03)	(8.63)	(7.13)	(3.78)
Other line items
Cash ROIC Full definition →		(26.15%)	(20.15%)	(19.39%)	(24.09%)
Accounts Receivable Turnover Full definition →		3.62	2.02	2.22	3.05
Accounts Payable Turnover Full definition →		8.58	3.57	2.71	3.31
Inventory Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		73.21	93.20	120.54	87.36
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	(0.01)	(0.01)
Research and Development Expense of Revenue Full definition →		1,093.33%	636.40%	652.83%	719.19%
Selling, General and Administrative Expense of Revenue Full definition →		503.83%	236.46%	235.71%	276.02%
Share Based Compensation of Revenue Full definition →		270.65%	148.93%	146.64%	165.38%
Operating CF/Net income Full definition →		0.62	0.58	0.57	0.68
Depreciation/Fixed assets Full definition →		0.69	0.81	0.88	0.87
Capex/Depreciation Full definition →		(0.12)	(0.10)	(0.08)	(0.05)
Revenue per Share Full definition →		0.10	0.17	0.13	0.10
Operating CF per Share Full definition →		(0.99)	(0.83)	(0.61)	(0.66)
Capex per Share Full definition →		(0.02)	(0.02)	(0.01)	(0.01)
Capex to Sales Full definition →		0.21	0.12	0.11	0.07

Show all line items

Columns are period end dates

Stockrow Weekly